Effects of 4-aminopyridine at the frog neuromuscular junction
- PMID: 21957
Effects of 4-aminopyridine at the frog neuromuscular junction
Abstract
Micromolar concentrations of 4-aminopyridine (4-AP) were able to increase the amplitude of the end-plate current in frog neuromuscular junction blocked either by d-tubocurarine or by low Ca++ high Mg++ medium. The end-plate potential was also increased. These effects were reversible. The changes in the end-plate current amplitude observed after 4-AP treatment had no effect on the end-plate current time course. There was no significant difference in the resting membrane potential or mean amplitude and frequency of spontaneous miniature end-plate potentials in the presence of 4-AP. The quantal content of the end-plate potential was increased in every preparation tested and the minimal synpatic delay was lengthened in a dose-related way. 4-AP did not modify the dependence of the amplitude of the end-plate current on membrane potential. In the presence of 4-AP, the time constant of the falling phase of the end-plate current remained an exponential function of the membrane potential. The end-plate current equilibrium potential was unaffected by 4-AP. The increase in the amount of acetylcholine released by nerve impulse induced by 4-AP occurs without modification in the calcium cooperativity. The authors suggest that 4-AP, by prolonging the presynaptic action potential, could increase calcium concentration in the nerve terminal and, thus, the transmitter release.
Similar articles
-
Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.Acta Physiol Pharmacol Latinoam. 1984;34(4):409-18. Acta Physiol Pharmacol Latinoam. 1984. PMID: 6242265
-
Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.J Pharmacol Exp Ther. 1983 Oct;227(1):260-5. J Pharmacol Exp Ther. 1983. PMID: 6137556
-
Modification by lithium of transmitter release at the neuromuscular junction of the frog.J Pharmacol Exp Ther. 1975 Aug;194(2):362-72. J Pharmacol Exp Ther. 1975. PMID: 239225
-
[Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].J Pharmacol. 1985;16 Suppl 2:109-44. J Pharmacol. 1985. PMID: 2417060 Review. French.
-
Spontaneous transmitter release at the neuromuscular junction.Fundam Clin Pharmacol. 1988;2(2):89-101. doi: 10.1111/j.1472-8206.1988.tb00625.x. Fundam Clin Pharmacol. 1988. PMID: 2899044 Review.
Cited by
-
Both ATP and the peptide VIP are inhibitory neurotransmitters in guinea-pig ileum circular muscle.J Physiol. 1992 Feb;447:119-31. doi: 10.1113/jphysiol.1992.sp018994. J Physiol. 1992. PMID: 1593443 Free PMC article.
-
Use of ion channel blockers in studying the regulation of skeletal muscle contractions.Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):691-7. doi: 10.1007/BF00174753. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1775201
-
Effect of the putative cognitive enhancer, linopirdine (DuP 996), on quantal parameters of acetylcholine release at the frog neuromuscular junction.Br J Pharmacol. 1994 Apr;111(4):1103-10. doi: 10.1111/j.1476-5381.1994.tb14858.x. Br J Pharmacol. 1994. PMID: 8032596 Free PMC article.
-
4-Aminopyridine blockade of neuronal depressant responses to adenosine triphosphate.Br J Pharmacol. 1980 Nov;70(3):425-8. doi: 10.1111/j.1476-5381.1980.tb08720.x. Br J Pharmacol. 1980. PMID: 7437650 Free PMC article.
-
Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease.J Neurosci. 1997 Jun 1;17(11):4500-7. doi: 10.1523/JNEUROSCI.17-11-04500.1997. J Neurosci. 1997. PMID: 9151766 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources